1250 MG testosterone 0.0162 MG/MG Topical Gel
- RxCUI
- 1597120
- RxNorm name
- 1250 MG testosterone 0.0162 MG/MG Topical Gel
- Display name
- 1250 MG testosterone 0.0162 MG/MG Topical Gel
- Full name
- 1250 MG testosterone 0.0162 MG/MG Topical Gel
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| testosterone | TESTOSTERONE | Northstar Rx LLC | 2d55b825-8eab-4091-bdf2-9c52d111b8eb | 2025-08-31 | Boxed warning, Warnings, Adverse reactions | 1597120 |
| testosterone | TESTOSTERONE | Padagis Israel Pharmaceuticals Ltd | 54fcdcb9-fb0e-4164-9e51-f2a5feae3217 | 2025-08-31 | Boxed warning, Warnings, Adverse reactions | 1597120 |
| Testosterone | TESTOSTERONE | Actavis Pharma, Inc. | 4f3c2c0a-7dab-4b50-9cae-869c3c2a8498 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 1597120 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f4e8d29b-8707-4d47-e053-2a95a90aecee | 1250 MG testosterone 0.0162 MG/MG Topical Gel | SCD | 130 | These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%. ANDROGEL ® (testosterone gel) 1.62% for topical use CIII Initial U.S. Approval: 1953 | 20251022 |
| f4e8d29b-8707-4d47-e053-2a95a90aecee | testosterone 1.62 % Transdermal Gel, 1.25 GM | SY | 130 | These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%. ANDROGEL ® (testosterone gel) 1.62% for topical use CIII Initial U.S. Approval: 1953 | 20251022 |
| f4e8d29b-8707-4d47-e053-2a95a90aecee | testosterone 1.62 % (20.25MG / 1.25GM) Transdermal Gel | PSN | 130 | These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%. ANDROGEL ® (testosterone gel) 1.62% for topical use CIII Initial U.S. Approval: 1953 | 20251022 |
| 54fcdcb9-fb0e-4164-9e51-f2a5feae3217 | 1250 MG testosterone 0.0162 MG/MG Topical Gel | SCD | 14 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1.62% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1.62% . TESTOSTERONE gel, for topical use CIII Initial U.S. Approval: 1953 | 20250831 |
| 54fcdcb9-fb0e-4164-9e51-f2a5feae3217 | testosterone 1.62 % Transdermal Gel, 1.25 GM | SY | 14 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1.62% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1.62% . TESTOSTERONE gel, for topical use CIII Initial U.S. Approval: 1953 | 20250831 |
| 54fcdcb9-fb0e-4164-9e51-f2a5feae3217 | testosterone 1.62 % (20.25MG / 1.25GM) Transdermal Gel | PSN | 14 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1.62% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1.62% . TESTOSTERONE gel, for topical use CIII Initial U.S. Approval: 1953 | 20250831 |
| 4f3c2c0a-7dab-4b50-9cae-869c3c2a8498 | testosterone 1.62 % (20.25MG / 1.25GM) Transdermal Gel | PSN | 11 | These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel for topical use CIII Initial U.S. Approval: 1953 | 20250801 |
| 4f3c2c0a-7dab-4b50-9cae-869c3c2a8498 | 1250 MG testosterone 0.0162 MG/MG Topical Gel | SCD | 11 | These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel for topical use CIII Initial U.S. Approval: 1953 | 20250801 |
| 4f3c2c0a-7dab-4b50-9cae-869c3c2a8498 | testosterone 1.62 % Transdermal Gel, 1.25 GM | SY | 11 | These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel for topical use CIII Initial U.S. Approval: 1953 | 20250801 |
| 2d55b825-8eab-4091-bdf2-9c52d111b8eb | testosterone 1.62 % Transdermal Gel, 1.25 GM | SY | 10 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1.62% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1.62% . TESTOSTERONE gel, for topical use CIII Initial U.S. Approval: 1953 | 20250831 |
| 2d55b825-8eab-4091-bdf2-9c52d111b8eb | testosterone 1.62 % (20.25MG / 1.25GM) Transdermal Gel | PSN | 10 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1.62% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1.62% . TESTOSTERONE gel, for topical use CIII Initial U.S. Approval: 1953 | 20250831 |
| 2d55b825-8eab-4091-bdf2-9c52d111b8eb | 1250 MG testosterone 0.0162 MG/MG Topical Gel | SCD | 10 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1.62% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1.62% . TESTOSTERONE gel, for topical use CIII Initial U.S. Approval: 1953 | 20250831 |